For Physicians
Company
Support
Sign in
Register
Home
Radiation Oncology
Question
How would the development of pneumonitis from pembrolizumab after treatment as per Keynote 522 alter your PMRT recommendations?
1 Answers
Add Answer
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
If recovered completely, I would proceed with PMRT.
Register
or
Sign In
to see full answer
